Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Intrauterine devices industry 3600 synopsis, 2018-2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Age group trends
2.1.4 Regional trends
Chapter 3 Intrauterine Devices Industry Insights
3.1 Industry landscape
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising awareness among women regarding various IUD applications
3.2.1.2 High number of unintended pregnancies
3.2.1.3 Government initiatives for the prevention of unwanted abortions and pregnancies
3.2.1.4 Growing inclination towards planned delayed pregnancy
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of device
3.2.2.2 Risk of several health issues
3.2.2.3 Variability in insurance coverage and access
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By age group
3.4 COVID- 19 impact analysis
3.5 Number of IUD insertions/procedures, by region, 2018 -2032 (number of procedures)
3.5.1 North America
3.5.1.1 Market estimates and forecasts, 2018 - 2032 (Number of procedures)
3.5.2 Europe
3.5.2.1 Market estimates and forecasts, 2018 - 2032 (Number of procedures)
3.5.3 RoW
3.5.3.1 Market estimates and forecasts, 2018 - 2032 (Number of procedures)
3.6 Pricing analysis, by region, 2021
3.6.1 North America
3.6.2 Europe
3.6.3 RoW
3.7 Regulatory landscape
3.7.1 U.S.
3.7.2 Europe
3.7.3 Asia Pacific
3.8 Future market trends
3.9 Technology landscape
3.10 Reimbursement scenario
3.10.1 North America
3.10.2 Europe
3.10.3 Asia Pacific
3.11 Gap analysis
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Competitive analysis of major market players
4.4 Competitive Positioning matrix
4.5 Strategy dashboard, 2021
Chapter 5 Intrauterine Devices Market, By Product
5.1 Key product trends
5.2 Copper IUD
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Hormonal IUD
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Intrauterine Devices Market, By Age Group
6.1 Key age group trends
6.2 15-19
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 20-24
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 25-29
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 30-34
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 35-39
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.7 40-44
6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.8 45+
6.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Intrauterine Devices Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Poland
7.3.7 Switzerland
7.3.8 Netherlands
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Indonesia
7.4.7 Thailand
7.4.8 Vietnam
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Chile
7.5.5 Colombia
7.5.6 Peru
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 Nigeria
7.6.4 Turkey
7.6.5 Iran
7.6.6 Egypt
Chapter 8 Company Profiles
8.1 Bayer AG
8.2 CooperSurgical Inc.
8.3 Allergan (AbbVie Inc.)
8.4 Pregna International Ltd.
8.5 OCON Medical
8.6 EUROGINE, S.L
8.7 HLL Lifecare Limited
8.8 Durbin
8.9 SMB Corporation of India
8.10 Gima S.p.A.
8.11 Meril Life Sciences Pvt. Ltd.
8.12 Prosan International BV
8.13 Mona Lisa
8.14 Contrel Europe
8.15 Mylan N.V. (Viatris)
